JACOBSON PHARMA(02633.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
JACOBSON PHARMA
02633.HK
Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare. The company offers generic drugs for various therapeutic categories, including cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergic. It also provides branded medicines; health and wellness products; proprietary Chinese medicines; treasury services; and management services.
1.239 T
02633.HKMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking34/53
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE12.97%B
    • Profit Margin19.73%A
    • Gross Margin44.07%B
  • Growth ScoreD
    • Revenue YoY-1.88%D
    • Net Profit YoY19.49%B
    • Total Assets YoY-2.19%D
    • Net Assets YoY-8.03%D
  • Cash ScoreC
    • Cash Flow Margin159.82%B
    • OCF YoY-1.88%D
  • Operating ScoreC
    • Turnover0.43C
  • Debt ScoreB
    • Gearing Ratio35.97%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    UOB Kay Hian Sticks to Its Buy Rating for Jacobson Pharma Corporation Limited (2633)

    Tip Ranks·
    HK
    02633
    -0.85%
    Tip Ranks·
    HK
    02633
    -0.85%

    JACOBSON PHARMA invested 600 million yuan to establish a factory in Tai Po

    AASTOCKS·
    HK
    02633
    -0.85%
    AASTOCKS·
    HK
    02633
    -0.85%

    JBM Healthcare and Jacobson Pharma Renew Connected Logistics Framework Through 2029

    Tip Ranks·
    SH
    512290
    -0.11%
    SH
    589720
    +1.03%
    SH
    513700
    -0.53%
    Tip Ranks·
    SH
    512290
    -0.11%
    SH
    589720
    +1.03%
    SH
    513700
    -0.53%

    "Performance" Jacobson Pharma's interim net profit is HKD 142 million, an increase of 1.2%, with a dividend of 4.25 cents

    AASTOCKS·
    HK
    02633
    -0.85%
    AASTOCKS·
    HK
    02633
    -0.85%

    Jacobson Pharma Reports Interim Results with Increased Shareholder Dividends

    Tip Ranks·
    HK
    02633
    -0.85%
    Tip Ranks·
    HK
    02633
    -0.85%
    © 2026 Longbridge｜Disclaimer